Therefore, due to the limited and conflicting evidence in the domestic population, it remains unclear whether FGF23, α-klotho and FGF23/α-klotho ratio are related to atherosclerosis in patients with T2DM. The gene discussed is FGF23; the disease is atherosclerosis.